Marktorientierter Akquisitionserfolg von Pharma- und Biotechnologieunternehmen. M. Kirchhoff and D. Schiereck. Publications of Darmstadt Technical University ...
Nov 1, 2008 · Die vorliegende Arbeit analysiert im Rahmen einer Ereignisstudie den Erfolg der weltweiten M&A-Aktivitäten in der Pharma- und ...
Jul 8, 2024 · The paper investigates the effect of mergers & acquisitions on product prices and uses the biopharmaceutical industry as the empirical setting.
Jul 7, 2022 · Jared Holz, Oppenheimer healthcare equity strategist, joins 'Power Lunch' to discuss the ...
Duration: 3:43
Posted: Jul 7, 2022
Duration: 3:43
Posted: Jul 7, 2022
Jun 21, 2024 · Just attended “The roadmap to success: From founding your biotech to a successful exit. Discover insights from Biotech, Pharma, ...
Feb 5, 2024 · Topping the 2023 list is Pfizer's $43 billion merger with Seagen. That deal, announced in mid-March, came amid a flurry of interest in the booming field of ...
Missing: Marktorientierter Akquisitionserfolg Biotechnologieunternehmen
Jan 28, 2016 · Evercore ISI's Umer Raffat, the sector's No. 1 analyst, is unabashedly bullish on speciality ...
Duration: 2:39
Posted: Jan 28, 2016
Duration: 2:39
Posted: Jan 28, 2016
Jan 31, 2024 · A quick reference of all the mergers and acquisitions that took place within the global pharmaceuticals market in 2024.
Missing: Marktorientierter Akquisitionserfolg Biotechnologieunternehmen
BioPharma Dive is tracking M&A activity below. The database, which shows drugmaker buyouts that have happened since 2018 and were valued at $50 million or more ...
Missing: Marktorientierter Akquisitionserfolg Biotechnologieunternehmen
Mar 7, 2022 · In the past, pharma and info device companies would engage universities and educational ...
Duration: 51:26
Posted: Mar 7, 2022
Duration: 51:26
Posted: Mar 7, 2022
In order to show you the most relevant results, we have omitted some entries very similar to the 10 already displayed.
If you like, you can repeat the search with the omitted results included. |